Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-k B)
URI: https://gptkb.org/entity/Nuclear_factor_kappa-light-chain-enhancer_of_activated_B_cells_%28NF-k_B%29
GPTKB entity
Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:NADPH_oxidase_complex
|
| gptkbp:associated_with |
inflammation
|
| gptkbp:composed_of |
p50 subunit
p65 subunit |
| gptkbp:discovered_by |
gptkb:David_Baltimore
|
| gptkbp:established |
apoptosis
cytokines |
| https://www.w3.org/2000/01/rdf-schema#label |
Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-k B)
|
| gptkbp:is_aimed_at |
anti-inflammatory drugs
|
| gptkbp:is_found_in |
gptkb:physicist
|
| gptkbp:is_involved_in |
gptkb:Company
gptkb:psychologist aging cell proliferation eye diseases immune response metabolic disorders antigen presentation autoimmune diseases chronic pain obesity wound healing B cell activation T cell activation liver disease neuroinflammation stress response fibrosis cardiovascular diseases cellular senescence cell survival tumor microenvironment skin diseases cancer progression atherosclerosis chronic inflammation tissue repair viral infections cell migration metastasis adaptive immunity kidney diseases cytokine production gastrointestinal diseases pulmonary diseases bone remodeling therapeutic resistance innate immunity muscle wasting neuropsychiatric disorders chemokine production |
| gptkbp:regulates |
gptkb:Iκ_B_proteins
gene expression |